"Unveiling Thrombotic and Thrombocytopenic Purpura: Pathogenesis, Clinical Features, and Treatment Strategies"

 

Thrombotic and Thrombocytopenic Purpura

Definition: TTP occurs in familial or acquired forms.

Pathogenesis: Deficiency of ADAMTS13 metalloprotease leads to ULVWF multimers.

Causes: Familial forms involve ADAMTS13 mutations;

Acquired forms result from inhibitory IgG autoantibodies.

Clinical Features: Pentad of symptoms: thrombocytopenia, microangiopathic hemolytic anemia, neurological abnormalities, renal failure, fever.

Treatment: Plasma exchange with FFP or cry supernatant, rituximab, alacizumab, and immunosuppressive therapies.

TTP is type of Thrombocytopenia mean platelets count decrease its normal count.

TTP is rare blood disorder characterized by clotting in small blood vessels (Thromboses) but unnecessary clot  resulting in a low platelet count.

Normally clotting present in tissue & vessels injury.

In TTP, Patient have defect in  (ADAMTS13) enzyme. ( For clearing the VWF multimers)

Normally

Gene to code for different protein.

ADAMTS13  gene its code for ADAMTS13 enzyme.

·         Function of ADAMTS13 enzyme

Cleavage of ultra-large VWF multimers into VWF monomers.

    

                         VWF  multimer                                          VWF monomer

                          (more active)                                           (less active)

Function of VWF

VWF secret it the time of injury.

Platelet stick together and adhere to the walls of blood vessels at the site of wound.

Platelets stick forms temporary clots, plugging holes in blood vessels walls to stop bleeding.

In case of TTP

In TTP defect is in the ADAMTS13 enzyme.

No cleavage of ultra large VWF multimers.

VWF multimers  increase

VWF monomers decrease

Two Types of TTP

1) Inherited

Inherited TTP is rare.

IT is a genetic disease called up show  Schulman  syndrome.

Deficiency of ADAMTS13  gene         deficiency of ADAMTS13 enzyme.

2) Acquired

This is common.

An inhibitor of this ADAMTS13 enzyme is present within the patient .

Nature of inhibitor of ADAMTS13        IgG  Antibody against it.

1)Primary haemostasias

TTP is a problem associated with primary haemostasias.

PLT count (PC)  decrease

Bleeding Time   increase

2)Secondary haemostasias

No effect of secondary haemostasias

PT (prothrombin time)   Normal

APTT  Normal

      Clinical Features: Pentad of symptoms:

Thrombocytopenia,

Microangiopathic hemolytic anemia,

Neurological abnormalities,

Renal failure,

Fever

TTP: Pathogenesis

Deficiency of ADAMTS13 leads to inability to break down ULVWF multimers.

ULVWF multimers bind platelets, causing thrombosis.

TTP: Clinical Features

Thrombocytopenia: <150,000 platelets/μL.

Microangiopathic Hemolytic Anemia: Presence of schistocytes.

Neurological Abnormalities: Confusion, seizures, focal shortages.

TTP: Diagnosis

Bilirubin                           Increase

Bleeding Time                             Increase 

HCT                                       Decrease

RBC                                       Decrease

Hb                                          Decrease

PLT  Count                      Decrease

MCV                                            Normal

PT                                                 Normal

APTT                                           Normal  

Peripheral smear             Schistocytes ( Half RBC’s)

ADAMTS13 activity test

 

Not only platelet disruption take place in TTP but only RBCs are effected.

TTP patients suffer from anemia also ( Normocytic)

RBC,s get ruptured when passed through the thrombi vessels therefore anemia develops and fragments which formed in these vessels are known as schistocytes.

In these patients  schistocytes present in blood.

Normal RBC,s shape change.

TTP: Treatment

Plasma exchange therapy: Removes ULVWF multimers and autoantibodies.

Immunosuppressive therapy: Steroids, rituximab.

References

Hoffbrand’s Essential Haematology, Eighth Edition. By A. Victor Hoffbrand and David P. Steensma. © 2020 John Wiley & Sons Ltd. Published 2020 by John Wiley & Sons Ltd. Companion website: www.wileyessential.com/haematology

 

 

https://pathologistforyou.blogspot.com/2024/05/streamlining-genomic-analysis.html 

https://pathologistforyou.blogspot.com/2024/03/grand-iftar-party-0n-28-march-2024-17.html 

https://pathologistforyou.blogspot.com/2024/03/exploring-biochemical-tests-in.html 

https://pathologistforyou.blogspot.com/2024/03/essential-practices-in-specimen.html 

https://pathologistforyou.blogspot.com/2024/03/essential-workplace-safety-guidelines.html 

https://pathologistforyou.blogspot.com/2024/03/understanding-trypanosoma-life-cycle.html 

https://pathologistforyou.blogspot.com/2024/03/understanding-trypanosoma-life-cycle.html 

https://pathologistforyou.blogspot.com/2024/03/malaria-caused-by-parasite-that.html 

https://pathologistforyou.blogspot.com/2024/03/understanding-trichomoniasismode-of.html 

https://pathologistforyou.blogspot.com/2024/03/understanding-giardiasis-definition.html 

https://pathologistforyou.blogspot.com/2024/03/first-short-notes-of-clinical.html 

https://pathologistfromkust.blogspot.com/2024/03/acute-lymphoblastic-leukemia-all-and.html 

https://pathologistfromkust.blogspot.com/2024/03/understanding-acute-myeloid-leukemia.html 

https://pathologistfromkust.blogspot.com/2024/03/comprehensive-overview-of-chronic.html 

https://pathologistfromkust.blogspot.com/2024/03/understanding-white-blood-cell.html 

 

 

Comments

Popular posts from this blog

First Short Notes of Clinical Parasitology (Amoebiasis Definition , Mode of Transmation, Life Cycle, Symptoms, Diagnosis and Treatment)

Understanding Giardiasis: Definition Mode of Transmission,Life cycle, Causes, Symptoms, Diagnosis, and Treatment

Understanding Trichomoniasis:Mode of Transmission, Symptoms, Diagnosis, Prevention, and Treatment